Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05827978 · ClinicalTrials.gov registry record · Phase 3
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
A Phase 3 study, sponsored by ModernaTX.
- Completed
- Registry status
- Phase 3
- Development phase
- 8,411
- Enrollment target
NCT05827978 is a Phase 3 study that has completed, run by ModernaTX. The registered enrollment target is 8,411 participants.
The verdict
NCT05827978, a Phase 3 study, has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 8,411 participants
- Enrollment target
Study Summary
This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults.
Interventions
- BIOLOGICAL mRNA-1010
- BIOLOGICAL Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,411 participants |
| Start Date | 2023-04-17 |
| Est. Completion | 2024-06-24 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05827978
The ClinicalTrials.gov registry entry for NCT05827978 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 8,411 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which mRNA-1010 is the first listed.
NCT05827978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05827978 about?
NCT05827978 is a clinical study titled "Study of mRNA-1010 Seasonal Influenza Vaccine in Adults". This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults.
What is the current status of trial NCT05827978?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 8,411 participants. The study started on 2023-04-17. Estimated completion is 2024-06-24.
What interventions are being tested in trial NCT05827978?
The interventions under investigation include: mRNA-1010 (BIOLOGICAL), Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05827978?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.